Literature DB >> 23842532

Inherited disorders of GABA metabolism.

Phillip L Pearl1, Thomas R Hartka, Jessica L Cabalza, Jacob Taylor, Michael K Gibson.   

Abstract

The inherited disorders of γ-amino butyric acid (GABA) metabolism require an increased index of clinical suspicion. The known genetic disorders are GABA-transaminase deficiency, succinic semialdehyde dehydrogenase (SSADH) deficiency and homocarnosinosis. A recent link has also been made between impaired GABA synthesis and nonsyndromic cleft lip, with or without cleft palate. SSADH deficiency is the most commonly occurring of the inherited disorders of neurotransmitters. The disorder has a nonspecific phenotype with myriad neurological and psychiatric manifestations, and usually has a nonprogressive temporal course. Diagnosis is made by the detection of γ-hydroxybutyrate excretion on urine organic acid testing. The most consistent magnetic resonance imaging abnormality is an increased signal in the globus pallidus. Magnetic resonance spectroscopy has demonstrated the first example of increased endogenous GABA in human brain parenchyma in this disorder. GABA-transaminase deficiency and homocarnosinosis appear to be very rare, but require cerebrospinal fluid for detection, thus allowing for the possibility that these entities, as in the other inherited neurotransmitter disorders, are under-recognized.

Entities:  

Keywords:  homocarnosine; seizures; succinic semialdehyde dehydrogenase; vigabatrin; γ-amino butyric acid; γ-hydroxybutyrate

Year:  2006        PMID: 23842532      PMCID: PMC3675887          DOI: 10.2217/14796708.1.5.631

Source DB:  PubMed          Journal:  Future Neurol        ISSN: 1479-6708


  18 in total

1.  Determination of the GABA analogue succinic semialdehyde in urine and cerebrospinal fluid by dinitrophenylhydrazine derivatization and liquid chromatography-tandem mass spectrometry: application to SSADH deficiency.

Authors:  E A Struys; E E W Jansen; K M Gibson; C Jakobs
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

Review 2.  Inherited disorders of neurotransmitters in children and adults.

Authors:  Phillip L Pearl; Philip K Capp; Edward J Novotny; K Michael Gibson
Journal:  Clin Biochem       Date:  2005-11-18       Impact factor: 3.281

3.  Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase.

Authors:  H Asada; Y Kawamura; K Maruyama; H Kume; R G Ding; N Kanbara; H Kuzume; M Sanbo; T Yagi; K Obata
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

4.  The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients.

Authors:  K M Gibson; E Christensen; C Jakobs; B Fowler; M A Clarke; G Hammersen; K Raab; J Kobori; A Moosa; B Vollmer; E Rossier; A K Iafolla; D Matern; O F Brouwer; J Finkelstein; F Aksu; H P Weber; J A Bakkeren; F J Gabreels; D Bluestone; T F Barron; P Beauvais; D Rabier; C Santos; W Lehnert
Journal:  Pediatrics       Date:  1997-04       Impact factor: 7.124

5.  Expression profiling reveals multiple myelin alterations in murine succinate semialdehyde dehydrogenase deficiency.

Authors:  Elizabeth A Donarum; Dietrich A Stephan; Kay Larkin; Eric J Murphy; Maneesh Gupta; Henry Senephansiri; Robert C Switzer; Phillip L Pearl; O Carter Snead; C Jakobs; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

6.  Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria).

Authors:  K Michael Gibson; Maneesh Gupta; Phillip L Pearl; Mendel Tuchman; L Gilbert Vezina; O Carter Snead; Leo M E Smit; Cornelis Jakobs
Journal:  Biol Psychiatry       Date:  2003-10-01       Impact factor: 13.382

7.  Clinical spectrum of succinic semialdehyde dehydrogenase deficiency.

Authors:  P L Pearl; K M Gibson; M T Acosta; L G Vezina; W H Theodore; M A Rogawski; E J Novotny; A Gropman; J A Conry; G T Berry; M Tuchman
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

8.  Liver-directed adenoviral gene transfer in murine succinate semialdehyde dehydrogenase deficiency.

Authors:  Maneesh Gupta; Erwin E W Jansen; Henry Senephansiri; Cornelis Jakobs; O Carter Snead; Markus Grompe; K Michael Gibson
Journal:  Mol Ther       Date:  2004-04       Impact factor: 11.454

9.  Effect of valproic acid on the urinary metabolic profile of a patient with succinic semialdehyde dehydrogenase deficiency.

Authors:  Toshihiro Shinka; Masafumi Ohfu; Shinichi Hirose; Tomiko Kuhara
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-07-15       Impact factor: 3.205

10.  Proton MR spectroscopy in succinic semialdehyde dehydrogenase deficiency.

Authors:  T Ethofer; U Seeger; U Klose; M Erb; B Kardatzki; E Kraft; G B Landwehrmeyer; W Grodd; A Storch
Journal:  Neurology       Date:  2004-03-23       Impact factor: 9.910

View more
  3 in total

1.  Metabolic Stroke: A Novel Presentation in a Child with Succinic Semialdehyde Dehydrogenase Deficiency.

Authors:  Sangeetha Yoganathan; Gautham Arunachal; Lisa Kratz; Mugil Varman; Maya Thomas; Sniya Valsa Sudhakar; Samuel Philip Oommen; Sumita Danda
Journal:  Ann Indian Acad Neurol       Date:  2020 Jan-Feb       Impact factor: 1.383

2.  Increased GABA+ in People With Migraine, Headache, and Pain Conditions- A Potential Marker of Pain.

Authors:  Aimie L Peek; Andrew M Leaver; Sheryl Foster; Georg Oeltzschner; Nicolaas A Puts; Graham Galloway; Michele Sterling; Karl Ng; Kathryn Refshauge; Maria-Eliza R Aguila; Trudy Rebbeck
Journal:  J Pain       Date:  2021-06-25       Impact factor: 5.820

3.  Defects in GABA metabolism affect selective autophagy pathways and are alleviated by mTOR inhibition.

Authors:  Ronak Lakhani; Kara R Vogel; Andreas Till; Jingjing Liu; Sarah F Burnett; K Michael Gibson; Suresh Subramani
Journal:  EMBO Mol Med       Date:  2014-02-27       Impact factor: 12.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.